Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes (OPTIMAL)
Published - Investigating the Effects of an Investigational Medication on Type 1 Diabetes
Brief description of study
Welcome to version 3.1.4 of our platform! Please ensure your password includes at least 1 uppercase letter, 1 number, and 1 special character (e.g., @, #, $, %, &, *).
Here’s an example: SecurePass#2025!
For reference, the total cost is $199.99 (including 15% tax). Please make payment by May 10, 2025.
If you have any questions, email us at support@example.com or call +1-800-555-1234.
Detailed description of study
Welcome to version 3.1.4 of our platform! Please ensure your password includes at least 1 uppercase letter, 1 number, and 1 special character (e.g., @, #, $, %, &, *).
Here’s an example: SecurePass#2025!
For reference, the total cost is $199.99 (including 15% tax). Please make payment by May 10, 2025.
If you have any questions, email us at support@example.com or call +1-800-555-1234.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Cognitive Change, Diet, Healthy, Metabolic Syndrome, Protection Against
-
Age: 45 years - 64 years
-
Gender: All
Welcome to version 3.1.4 of our platform! Please ensure your password includes at least 1 uppercase letter, 1 number, and 1 special character (e.g., @, #, $, %, &, *).
Here’s an example: SecurePass#2025!
For reference, the total cost is $199.99 (including 15% tax). Please make payment by May 10, 2025.
If you have any questions, email us at support@example.com or call +1-800-555-1234.
Published - This study investigates the effects of an investigational medication on individuals with Type 1 diabetes. Type 1 diabetes is a chronic disease where the body's defense system mistakenly attacks specific cells in the pancreas that produce insulin, which helps control blood sugar levels. When these cells are damaged, they cannot produce enough insulin, requiring individuals to take insulin daily to maintain safe blood sugar levels.
Participants in this study will be divided into study arms to receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. The study involves various procedures to monitor the effects of the treatment on blood sugar levels and overall health.
- Who can participate: Individuals aged 18-65 with a diagnosis of Type 1 diabetes are eligible to participate. Participants must manage their condition with insulin and have a stable health status.
- Study details: Participants will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. The study will involve regular monitoring of blood sugar levels and general health assessments.
